Skip to content
healthcare.dev

ARISTADA

NDC 65757-401, aripiprazole lauroxil, injection, suspension, extended release, from Alkermes, Inc..

Product NDC
65757-401
Status
Listed
Labeler
Alkermes, Inc.
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207533
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65757-401 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ARIPIPRAZOLE LAUROXIL441 mg/1.6mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
65757-401-03657570401031 SYRINGE in 1 CARTON (65757-401-03) / 1.6 mL in 1 SYRINGE
65757-401-04657570401041 SYRINGE in 1 CARTON (65757-401-04) / 1.6 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/17a8d11b-73b0-4833-a0b4-cf1ef85edefb
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65757-401
  • NADAC price for package 65757040103

    GET /v1/drugs/nadac/65757040103

Use it

Look up 65757-401 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65757-401 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65757-401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.